Wyatt D. Geist - 01 May 2026 Form 4 Insider Report for Tenon Medical, Inc. (TNON)

Reporting relationship: Chief Innovation Officer
Issuer ticker: TNON
Reported as of: 01 May 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 05 May 2026, 19:42:16 UTC
Prior SEC filing: 18 Nov 2025
Source filing: View source filing
Reporting owner signature: /s/ Wyatt Geist

Filing notes and source

Key filing fact

Wyatt D. Geist filed Form 4 for Tenon Medical, Inc. (TNON) on 05 May 2026.

Key facts

This page summarizes Wyatt D. Geist's Form 4 filing for Tenon Medical, Inc. (TNON).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 05 May 2026, 19:42.

Change

Previous filing in this sequence was filed on 18 Nov 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002080676 Primary reporting owner

Geist Wyatt D.

Relationship: Chief Innovation Officer
Address: 104 COOPER CT., LOS GATOS
Signature: /s/ Wyatt Geist
Signature date: 05 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TNON transaction

Common stock

Award

Transaction value
Shares: +136,401
Change %: +39%
Price: $0.000000^*
Shares after: 487,166
Date: 01 May 2026
Ownership: By SiVantage, Inc.
Footnotes: F1

TNON holding

Common stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 157,569
Date: 01 May 2026
Ownership: Direct

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

On May 1, 2026, Tenon Medical, Inc. ("Registrant") issued 276,228 shares of its common stock to SiVantage, Inc. ("SiVantage") pursuant to the Asset Purchase Agreement, dated August 1, 2025, by and between the Registrant and SiVantage, in connection with the achievement of a certain milestone set forth therein. The securities reported herein represent the reporting person's indirect pecuniary interest in the shares held by SiVantage based on the reporting person's 49.38% equity interest in SiVantage. The reporting person disclaims beneficial ownership except to the extent of his pecuniary interest.